0001213900-21-058209.txt : 20211110 0001213900-21-058209.hdr.sgml : 20211110 20211110172429 ACCESSION NUMBER: 0001213900-21-058209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211110 DATE AS OF CHANGE: 20211110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: David Matthew T CENTRAL INDEX KEY: 0001811612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 211397941 MAIL ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2021-11-01 false 0001410098 CorMedix Inc. CRMD 0001811612 David Matthew T C/O CORMEDIX INC. 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS NJ 07922 false true false false Interim CEO and CFO Common Stock 1150.0000 D Stock Option (Right to Buy Common Stock) 5.5600 2021-11-01 4 A false 125000.0000 0.0000 A 2031-11-01 Common Stock 125000.0000 125000.0000 D Stock Option (Right to Buy Common Stock) 8.3200 2031-01-11 Common Stock 80000.0000 80000.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-05-11 Common Stock 125000.0000 125000.0000 D Stock Option (Right to Buy Common Stock) 4.0800 2030-05-11 Common Stock 125000.0000 125000.0000 D These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date. /s/ Matthew T. David 2021-11-10